Daoud Meerzaman

Daoud Meerzaman is an Adjunct Professor of Biology at the George Washington University. His expertise spans translational research in clinical oncology, cancer genomics, proteo-genomics, precision medicine, and the identification of novel molecular targets and treatments.

• B.S., M.S., and Doctorate in Biology from George Washington University
• Fellowship at Children’s National Medical Center in Washington D.C. and a joint program at the University of Maryland at Baltimore and Johns Hopkins University

His research focuses on cancer genomics and precision medicine, particularly in mutation detection, multi-omics clustering of high-risk cancer patients, and the development of computational tools like gcMECM for analyzing cancer mutations. Recent publications highlight cross-platform benchmarking of sequencing technologies, alternative polyadenylation in lung cancer, and germline genetic variants in astrocytoma patients.

Daoud Meerzaman’s work in 2021 emphasizes the application of whole-genome and exome sequencing to improve cancer diagnostics and therapy. Collaborative projects include establishing reference datasets for mutation detection, TNF signaling in inflammation, and molecular profiling of exceptional responders to cancer treatments.